Global Reporting Initiative (GRI) G3.1 Allergan Index

EN28. Monetary value of significant fines and totalnumber of non-monetary sanctions for non-compliancewith environmental laws and regulations.EN29. Significant environmental impacts oftransporting products and other materials and goodsused for the organization’s operations, and transportingmembers of the workforce.EN30. Total environmental protection expenditures andinvestments by type.Social PerformanceManagement ApproachLA1. Total workforce by employment type, employmentcontract and region.LA2. Total number and rate of employee turnover byage group, gender and region.LA3. Benefits provided to full-time employees notprovided to part-time or temporary employees, bymajor operations.LA4. Percentage of employees covered by collectivebargaining agreements.LA5. Minimum notice periods regarding operationalchanges, including whether it is specified in collectiveagreements.LA6. Percentage of workforce represented in formalEHSResponsibility - EHSSustainability Performance Report; summary tablelocated in back of the ReportEHSResponsibility - EHSSustainability Performance Report; summary tablelocated in back of the ReportEHSResponsibility - EHSSustainability Performance Report; summary tablelocated in back of the ReportEnvironmental CostsHealth and Safety CostsAllergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsResearch and DevelopmentProduct Safety and Animal TestingAllergan Commitment to Human RightsAllergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsSustainability Performance Report see page 23Allergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsSustainability Performance Report see page 23Allergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsAllergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsAllergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsEHS